Cleared Traditional

K221870 - CarnaLife Holo (FDA 510(k) Clearance)

May 2023
Decision
307d
Days
Class 2
Risk

K221870 is an FDA 510(k) clearance for the CarnaLife Holo. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Medapp S.A. (Krakow, PL). The FDA issued a Cleared decision on May 1, 2023, 307 days after receiving the submission on June 28, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K221870 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2022
Decision Date May 01, 2023
Days to Decision 307 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050